Search research articles
Contact Us
Filters
Showing results (151-160 of 161) with videos related to
Page
of 17
Sort By:
International Journal of Radiation Oncology, Biology, Physics
|
September 22, 2018
In Regard to Bossi et al
Carole Fakhry, Phuc Felix Nguyen-Tân, Louise Lambert, et al.
International Journal of Radiation Oncology, Biology, Physics
|
October 5, 2021
The Clinical Cell-Cycle Risk (CCR) Score Is Associated With Metastasis After Radiation Therapy and Provides Guidance on When to Forgo Combined Androgen Deprivation Therapy With Dose-Escalated Radiation
Jonathan Tward, Lauren Lenz, Darl D Flake, et al.
Cancer Research
|
April 25, 2018
Workshop Report for Cancer Research: Defining the Shades of Gy: Utilizing the Biological Consequences of Radiotherapy in the Development of New Treatment Approaches-Meeting Viewpoint
Mansoor M Ahmed, C Norman Coleman, Marc Mendonca, et al.
Nature Cancer
|
December 28, 2022
Author Correction: A phase I/Ib trial and biological correlate analysis of neoadjuvant SBRT with single-dose durvalumab in HPV-unrelated locally advanced HNSCC
Laurel B Darragh, Michael M Knitz, Junxiao Hu, et al.
Nature Cancer
|
November 26, 2022
A phase I/Ib trial and biological correlate analysis of neoadjuvant SBRT with single-dose durvalumab in HPV-unrelated locally advanced HNSCC
Laurel B Darragh, Michael M Knitz, Junxiao Hu, et al.
Nature Cancer
|
January 10, 2024
Publisher Correction: A phase I/Ib trial and biological correlate analysis of neoadjuvant SBRT with single-dose durvalumab in HPV-unrelated locally advanced HNSCC
Laurel B Darragh, Michael M Knitz, Junxiao Hu, et al.
JCO Precision Oncology
|
August 11, 2022
Changes in Circulating Tumor DNA Reflect Clinical Benefit Across Multiple Studies of Patients With Non-Small-Cell Lung Cancer Treated With Immune Checkpoint Inhibitors
Diana Merino Vega, Katherine K Nishimura, Névine Zariffa, et al.
Molecular Oncology
|
April 24, 2013
A patient tumor transplant model of squamous cell cancer identifies PI3K inhibitors as candidate therapeutics in defined molecular bins
Stephen B Keysar, David P Astling, Ryan T Anderson, et al.
Journal of the National Comprehensive Cancer Network : JNCCN
|
January 7, 2016
Prostate Cancer, Version 1.2016
James L Mohler, Andrew J Armstrong, Robert R Bahnson, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
April 18, 2018
Report from the SWOG Radiation Oncology Committee: Research Objectives Workshop 2017
Paul Okunieff, Katherine Casey-Sawicki, Natalie A Lockney, et al.
Page
of 17
Search research articles
Search
Showing results (151-160 of 161) with videos related to
Sort By:
Page
of 17
International Journal of Radiation Oncology, Biology, Physics
|
September 22, 2018
In Regard to Bossi et al
Carole Fakhry, Phuc Felix Nguyen-Tân, Louise Lambert, et al.
International Journal of Radiation Oncology, Biology, Physics
|
October 5, 2021
The Clinical Cell-Cycle Risk (CCR) Score Is Associated With Metastasis After Radiation Therapy and Provides Guidance on When to Forgo Combined Androgen Deprivation Therapy With Dose-Escalated Radiation
Jonathan Tward, Lauren Lenz, Darl D Flake, et al.
Cancer Research
|
April 25, 2018
Workshop Report for Cancer Research: Defining the Shades of Gy: Utilizing the Biological Consequences of Radiotherapy in the Development of New Treatment Approaches-Meeting Viewpoint
Mansoor M Ahmed, C Norman Coleman, Marc Mendonca, et al.
Nature Cancer
|
December 28, 2022
Author Correction: A phase I/Ib trial and biological correlate analysis of neoadjuvant SBRT with single-dose durvalumab in HPV-unrelated locally advanced HNSCC
Laurel B Darragh, Michael M Knitz, Junxiao Hu, et al.
Nature Cancer
|
November 26, 2022
A phase I/Ib trial and biological correlate analysis of neoadjuvant SBRT with single-dose durvalumab in HPV-unrelated locally advanced HNSCC
Laurel B Darragh, Michael M Knitz, Junxiao Hu, et al.
Nature Cancer
|
January 10, 2024
Publisher Correction: A phase I/Ib trial and biological correlate analysis of neoadjuvant SBRT with single-dose durvalumab in HPV-unrelated locally advanced HNSCC
Laurel B Darragh, Michael M Knitz, Junxiao Hu, et al.
JCO Precision Oncology
|
August 11, 2022
Changes in Circulating Tumor DNA Reflect Clinical Benefit Across Multiple Studies of Patients With Non-Small-Cell Lung Cancer Treated With Immune Checkpoint Inhibitors
Diana Merino Vega, Katherine K Nishimura, Névine Zariffa, et al.
Molecular Oncology
|
April 24, 2013
A patient tumor transplant model of squamous cell cancer identifies PI3K inhibitors as candidate therapeutics in defined molecular bins
Stephen B Keysar, David P Astling, Ryan T Anderson, et al.
Journal of the National Comprehensive Cancer Network : JNCCN
|
January 7, 2016
Prostate Cancer, Version 1.2016
James L Mohler, Andrew J Armstrong, Robert R Bahnson, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
April 18, 2018
Report from the SWOG Radiation Oncology Committee: Research Objectives Workshop 2017
Paul Okunieff, Katherine Casey-Sawicki, Natalie A Lockney, et al.
Page
of 17